Steven T. Harris

18.1k total citations · 10 hit papers
76 papers, 12.9k citations indexed

About

Steven T. Harris is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Steven T. Harris has authored 76 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Orthopedics and Sports Medicine, 50 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Steven T. Harris's work include Bone health and osteoporosis research (56 papers), Bone health and treatments (50 papers) and Bone and Joint Diseases (19 papers). Steven T. Harris is often cited by papers focused on Bone health and osteoporosis research (56 papers), Bone health and treatments (50 papers) and Bone and Joint Diseases (19 papers). Steven T. Harris collaborates with scholars based in United States, Switzerland and Canada. Steven T. Harris's co-authors include Harry K. Genant, Nelson B. Watts, Paul D. Miller, Michael R. McClung, E. Michael Lewiecki, Charles H. Chesnut, Stuart L. Silverman, Neil Binkley, Steven M. Petak and Pauline M. Camacho and has published in prestigious journals such as New England Journal of Medicine, JAMA and Endocrine Reviews.

In The Last Decade

Steven T. Harris

76 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

1999 1.9k citations Steven T. Harris profile →
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary

2016 939 citations Steven T. Harris, E. Michael Lewiecki et al. Endocrine Practice profile →
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

2000 785 citations Charles H. Chesnut, Stuart L. Silverman et al. The American Journal of Medicine profile →
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

1990 753 citations Nelson B. Watts, Steven T. Harris et al. New England Journal of Medicine profile →
Noninvasive assessment of bone mineral and structure: State of the art

1996 731 citations Harry K. Genant, Steven T. Harris et al. profile →
American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

2020 659 citations Steven T. Harris, E. Michael Lewiecki et al. Endocrine Practice profile →
Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases

2006 567 citations Ethel S. Siris, Steven T. Harris et al. profile →
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

2005 555 citations Douglas C. Bauer, David W. Dempster et al. profile →
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

2014 438 citations Ethel S. Siris, Robert A. Adler et al. Osteoporosis International profile →
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016

2016 359 citations Steven T. Harris, E. Michael Lewiecki et al. Endocrine Practice profile →

Peers

Countries citing papers authored by Steven T. Harris

Since Specialization

Citations

This map shows the geographic impact of Steven T. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven T. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven T. Harris more than expected).

Fields of papers citing papers by Steven T. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven T. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven T. Harris. The network helps show where Steven T. Harris may publish in the future.

Co-authorship network of co-authors of Steven T. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Steven T. Harris. A scholar is included among the top collaborators of Steven T. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven T. Harris. Steven T. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	History of etidronate 2020 ·Bone ·Nelson B. Watts, Charles H. Chesnut, Harry K. Genant, Steven T. Harris, Rebecca D. Jackson, Angelo A. Licata, Paul D. Miller, W. Jerry Mysiw, Bradford J. Richmond, David Valent	29
2	Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis 2017 ·Journal of Clinical Densitometry ·E. Michael Lewiecki, John P. Bilezikian, John Carey, Richard Dell, Catherine M. Gordon, Steven T. Harris, Michael R. McClung, Paul D. Miller, Michael Rosenblatt	12
3	Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years 2017 ·Osteoporosis International ·Ankita Modi, (unknown), (unknown), Jessica Weaver, E. Michael Lewiecki, Steven T. Harris	32
4	Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population 2016 ·Clinical Therapeutics ·Ankita Modi, Shiva Sajjan, E. Michael Lewiecki, Steven T. Harris, Jessica Weaver	6
5	The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group breakdown → 2014 ·Osteoporosis International ·Ethel S. Siris, Robert A. Adler, John P. Bilezikian, Michael A. Bolognese, Bess Dawson‐Hughes, Murray J. Favus, Steven T. Harris, Suzanne M. Jan de Beur, Sundeep Khosla, N.E. Lane, Robert Lindsay, Arvind Nana, Eric Orwoll, Kenneth G. Saag, Stuart L. Silverman, Nelson B. Watts	438
6	Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday 2012 ·The American Journal of Medicine ·Michael R. McClung, Steven T. Harris, Paul D. Miller, Douglas C. Bauer, K. Shawn Davison, Larry Dian, David A. Hanley, David L. Kendler, Chui Kin Yuen, E. Michael Lewiecki	353
7	Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond 2009 ·The American Journal of Medicine ·Kelly Davison, David L. Kendler, Patrick Ammann, Douglas C. Bauer, David W. Dempster, Larry Dian, David A. Hanley, Steven T. Harris, Michael R. McClung, Wojciech P. Olszynski, Chui Kin Yuen	15
8	Progression of Efficacy with Ibandronate 2007 ·Annals of the New York Academy of Sciences ·Mone Zaidi, Solomon Epstein, Steven T. Harris, Joseph D. Kohles, Charles H. Chesnut	11
9	Clinical Use of Teriparatide in the Real World: Initial Insights 2004 ·Endocrine Practice ·Paul D. Miller, John P. Bilezikian, Chad Deal, Steven T. Harris, Roberto Pacifici	27
10	Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Pierre D. Delmas, Kristine E. Ensrud, Jonathan D. Adachi, Kristine D. Harper, Somnath Sarkar, C. Gennari, Jean‐Yves Reginster, Huibert A. P. Pols, Robert R. Recker, Steven T. Harris, Wentao Wu, Harry K. Genant, Dennis M. Black, Richard Eastell	438
11	In Vivo Assessment of Architecture and Micro-Finite Element Analysis Derived Indices of Mechanical Properties of Trabecular Bone in the Radius 2002 ·Osteoporosis International ·Bert van Rietbergen, G.v. Ingersleben, C. H. Chesnut, Brian MacDonald, Harry K. Genant, D. C. Newitt, Sharmila Majumdar, Steven T. Harris, Patrick Garnero	130
12	The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial 2000 ·Open Repository and Bibliography (University of Liège) ·Richard Eastell, Jonathan D. Adachi, Kristine D. Harper, Somnath Sarkar, PD Delmas, Kristine E. Ensrud, C. Gennari, Jean‐Yves Reginster, H. A. P. Pols, Robert R. Recker, Steven T. Harris, Wei Wu, H K Genant, D Black	6
13	Assessment of Vertebral Bone Mineral Density Using Volumetric Quantitative CT 1999 ·Journal of Computer Assisted Tomography ·Thomas Lang, Jing Li, Steven T. Harris, Harry K. Genant	121
14	Calcitonin treatment for central giant cell granulomas of the mandible: Report of two cases 1999 ·Journal of Oral and Maxillofacial Surgery ·M. Anthony Pogrel, Joseph A. Regezi, Steven T. Harris, Steven R. Goldring	75
15	The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis 1998 ·Open Repository and Bibliography (University of Liège) ·Kristine E. Ensrud, D Black, Robert R. Recker, Steven T. Harris, Pierre Delmas, H. A. P. Pols, Jean‐Yves Reginster, N. H. Bjarnason, C. Gennari, (unknown), Ronald K. Knickerbocker, Richard Eastell, Jonathan D. Adachi, B. Mitlak	17
16	Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension 1997 ·Journal of Human Hypertension ·(unknown), (unknown), (unknown), (unknown), (unknown), Steven T. Harris, (unknown), (unknown), Rafael J. Montoro, (unknown), (unknown), Sidney Rosenblatt, (unknown), (unknown), (unknown)	11
17	Four-Year Study of Intermittent Cyclic Etidronate Treatment of Postmenopausal Osteoporosis 1994 ·Obstetrical & Gynecological Survey ·Steven T. Harris, Nelson B. Watts, Rebecca D. Jackson, Harry K. Genant, Richard D. Wasnich, Philip D. Ross, Paul D. Miller, Angelo A. Licata, Charles Chestnut	1
18	Improved Mineral Balance and Skeletal Metabolism in Postmenopausal Women Treated with Potassium Bicarbonate 1994 ·New England Journal of Medicine ·Anthony Sebastián, Steven T. Harris, J. H. Ottaway, Karen Todd, R. Curtis Morris	411
19	The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. 1993 ·The Journal of Clinical Endocrinology & Metabolism ·Steven T. Harris, B. J. Gertz, Harry K. Genant, David W. Eyre, (unknown), (unknown), (unknown), (unknown), C. H. Chesnut	148
20	Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis 1991 ·Obstetrical & Gynecological Survey ·Nelson B. Watts, Steven T. Harris, Harry K. Genant, (unknown), Paul D. Miller, Rebecca D. Jackson, Angelo A. Licata, Philip D. Ross, (unknown), (unknown), W. Jerry Mysiw, Larry M. Kohse, (unknown), Peter Steiger, Bradford J. Richmond, (unknown)	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact